Immunoassay using optical interference detection

• US 4,647,544 A
• Filed: 06/25/1984
• Issued: 03/03/1987
• Est. Priority Date: 06/25/1984
• Status: Expired due to Term

• Current Assignee: Nicoli, David F., Virgil B. Elings
• Original Assignee: Nicoli, David F., Virgil B. Elings
• Inventors: Nicoli, David F., Elings, Virgil B.
• Primary Examiner(s): NOT, DEFINED
• Assistant Examiner(s): Wieder, Stephen C.
• Application Number:
  US06/624,460
• Time in Patent Office: 981 Days
• Field of Search: 436/518, 436/519, 436/527, 436/528, 436/531, 436/805, 436/807, 436/909, 356/317, 356/318, 250/461.1
• US Class Current: 436/518
• CPC Class Codes: G01N 2021/4711 Multiangle measurement
• CPC Class Codes: G01N 21/4788 Diffraction for sizing particles G01N15/0205
• CPC Class Codes: G01N 33/54373 involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
• CPC Class Codes: G01N 33/554 the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
• CPC Class Codes: Y10S 436/805 Optical property
• CPC Class Codes: Y10S 436/807 Apparatus included in process claim, e.g. physical support structures
• CPC Class Codes: Y10S 436/909 Nephelometry

Abstract

Apparatus and method for providing an optical detection of a binding reaction between a ligand and an antiligand, including, a pattern formed by a spatial array of microscopic dimensions of antiligand material, ligand material interacting with the antiligand material to produce a binding reaction between the ligand and the antiligand in the pattern, a source of optical radiation including energy at at least one wavelength directed to the pattern at a particular incidence angle to produce scattering of the energy from the pattern in accordance with the binding reaction and with a strong scattering intensity at one or more Bragg scattering angles, and at least one optical detector located relative to the pattern and aligned with a Bragg scattering angle to detect the strong scattering intensity at the Bragg scattering angle to produce a signal representative of the binding reaction.

Claims

1. An apparatus for providing an optical detection of a binding reaction between a ligand and an antiligand, including,

a predetermined pattern formed by a spatial array having a plurality of elements of microscopic dimensions of antiligand material,

ligand material interacting with the spatial array of antiligand material to produce a binding reaction between the ligand and the antiligand in the pattern,

a source of optical radiation directed toward the pattern to illuminate the plurality of elements of the spatial array to produce an optical interference pattern in accordance with the modulation of the optical properties of the predetermined antiligand pattern due to the binding reaction, and

one or more optical detectors to detect the strong scattering intensity at one or more angles to produce a signal representative of the binding reaction.

2. The apparatus of claim 1 wherein the predetermined pattern is formed by a plurality of stripes of antiligand material, each stripe having a width of microscopic dimensions and separated from each other by a constant microscopic dimension.

3. The apparatus of claim 2 wherein the plurality of stripes of antiligand material is formed by antiligand material supported on a flat continuous surface.

4. The apparatus of claim 1 wherein the spacial array is formed by antiligand material supported on a grooved surface forming an interference grating.

5. The apparatus of claim 1 including ligand attached to carrier particles which compete with the unknown ligand for binding sites on the antiligand material.

6. The apparatus of claim 1 including antiligand attached to carrier particles to cause a binding reaction with the ligand for increasing the signal representative of the binding reaction.

7. The apparatus of claim 1 wherein the optical detector is on the same side of the pattern as the source of optical radiation to detect backscattered, or reflected, radiation.

8. The apparatus of claim 1 wherein the optical detector is on the opposite side of the pattern as the source of optical radiation to detect forward scattered, or transmitted, radiation.

9. The apparatus of claim 1 wherein the ligand is attached to carrier particles which are biological entities, such as cells.

10. The apparatus of claim 9 wherein the ligand on the carrier particle is naturally occurring.

11. The apparatus of claim 1 wherein the pattern is formed by deactivating microscopic sections of an initially unform layer of an antiligand supported on a continuous surface.

12. The apparatus of claim 11 in which the deactivated sections consist of a plurality of stripes each stripe having a width of microscopic dimensions and separated from each other by a constant microscopic dimension.

14. The apparatus of claim 12 wherein the pattern is formed by a plurality of stripes of antibody material, each stripe having a width of microscopic dimensions and separated from each other by a constant microscopic dimension.

13. Apparatus for producing an output signal in accordance with a binding reacton between an antibody and an antigen, including,

a spatial array of antibody having a plurality of elements of microscopic dimensions to form a predetermined pattern,

antigen located in solution adjacent to the spatial array of antibody to interact with the antibody in a binding reaciton in the pattern,

an incident source of optical radiation and with the source being substantially coherent and monochromatic and directed to the pattern for illuminating the plurality of elements of the spatial array for producing an optical interference pattern at particular scattering angles in accordance with the modulation of the optical properties of the predetermined antibody pattern due to the binding reaction, and

one or more detectors located near the pattern at one or more of the particular scattering angles to intercept the radiation and produce an output signal in accordance with the binding reaction.

15. The apparatus of claim 13 wherein the pattern of antibody material is formed by antibody material supported on a flat continuous surface.

16. The apparatus of claim 13 wherein the spacial array of antibody is formed by antibody material supported on a grooved surface forming an interference grating.

17. The apparatus of claim 13 including antigen attached to carrier particles which competes with the unknown antigen for binding sites on the antibody material.

18. The apparatus of claim 13 including antibody attached to carrier particles to cause a binding reaction with the antigen for increasing the signal representative of the binding reaction.

19. The apparatus of claim 13 wherein the optical detector is on the same side of the pattern as the source of optical radiation to detect backscattered, or reflected, radiation.

20. The apparatus of claim 13 wherein the optical detector is on the opposite side of the pattern as the source of optical radiation to detect forward scattered, or transmitted radiation.

21. The apparatus of claim 13 wherein the antigen is attached to carrier particles which are biological entities.

22. The apparatus of claim 21 wherein the antigen on the carrier particle is naturally occurring.

23. The apparatus of claim 13 wherein the pattern is formed by deactivating microscopic sections of an initially uniform layer of an antibody supported on a continuous surface.

24. The apparatus of claim 23 in which the deactivated sections consist of a plurality of stripes each stripe having a width of microscopic dimensions and separated from each other by a constant microscopic dimension.

25. A method for providing an optical detection of a binding reaction between a ligand and an antiligand, including the following steps,

forming a predetermined pattern having a spatial array having a plurality of elements of microscopic dimensions of antiligand material,

providing ligand material to interact with the spatial array of antiligand material to produce a binding reaction between the ligand and the antiligand in the periodic pattern,

directing optical radiation including energy of at least one wavelength to the pattern for illuminating the plurality of elements of the spatial array to produce scattering of the energy from the pattern following the physical principle of constructive optical interference in accordance with the binding reaction and with a strong scattering intensity at one or more particular scattering angles, and

detecting the strong scattering intensity at one or more of the particular scattering angles to produce a signal representative of the binding reaction.

26. The method of claim 25 wherein the predetermined pattern is formed by a plurality of stripes of antiligand material, each stripe having a width of microscopic dimensions and separated from each other by a constant microscopic dimension.

27. The method of claim 26 wherein the plurality of stripes of antiligand material is formed by antiligand material supported on a flat continuous surface.

28. The method of claim 25 wherein the the spacial pattern of antiligand material is formed by antiligand material supported on a grooved surface forming an interference grating.

29. The method of claim 25 including ligand attached to carrier particles which competes with the unknown ligand for binding sites on the antiligand material.

30. The method of claim 25 including antiligand attached to carrier particles to cause a binding reaction with the ligand for increasing the signal representative of the binding reaction.

31. The method of claim 25 wherein the optical detection is on the same side of the pattern as the source of optical radiation to detect backscattered, or reflected, radiation.

32. The method of claim 25 wherein the optical detection is on the opposite side of the pattern as the source of optical radiation to detect forward scattered, or transmitted, radiation.

33. The method of claim 25 wherein the ligand is attached to carrier particles which are biological entities.

34. The method of claim 33 wherein the ligand on the carrier particle is naturally occurring.

35. The method of claim 25 wherein the pattern is formed by deactivating microscopic sections of an initially uniform layer of an antiligand.

36. The method of claim 35 in which the deactivated sections consist of a plurality of stripes each stripe having a width of microscopic dimensions and separated from each other by a constant microscopic dimension.

37. A method for producing an output signal in accordance with a binding reaction between an antibody and an antigen, including the following steps,

providing a spatial array of antibody having a plurality of elements of microscopic dimensions to form a predetermined pattern,

locating antigen in solution adjacent to the spatial array of antibody to interact with the antibody in a binding reaction in the pattern,

directing substantially coherent and monochromatic optical radiation to the pattern for illuminating the plurality of elements of the spatial array for producing scattering from the pattern at particular scattering angles due to optical interference in accordance with the binding reaction, and

detecting the scattered radiation to produce an output signal in accordance with the binding reaction.

38. The method of claim 37 wherein the regular pattern is formed by a plurality of stripes of antibody material, each stripe having a width of microscopic dimensions and separated from each other by a constant microscopic dimension.

39. The method of claim 38 wherein the plurality of stripes of antibody material is formed by antibody material supported on a flat continuous surface.

40. The method of claim 37 wherein the spacial pattern of antibody material is formed by antibody material supported on a grooved surface forming an interference grating.

41. The method of claim 37 including antigen attached to carrier particles which competes with the unknown antigen for binding sites on the antibody material.

42. The method of claim 37 including antibody attached to carrier particles to cause a binding reaction with the antigen for increasing the signal representative of the binding reaction.

43. The method of claim 37 wherein the optical detection is on the same side of the pattern as the source of optical radiation to detect backscattered, or reflected, radiation.

44. The method of claim 37 wherein the optical detection is on the opposite side of the pattern as the source of optical radiation to detect forward scattered, or transmitted, radiation.

45. The method of claim 37 wherein the antigen is attached to carrier particles which are biological entities.

46. The method of claim 45 wherein the antigen on the carrier particle is naturally occurring.

47. The method of claim 37 wherein the pattern is formed by deactivating microscopic sections of an initially uniform layer of an antiligand.

48. The method of claim 47 in which the deactivated sections consist of a plurality of stripes each stripe having a width of microscopic dimensions and separated from each other by a constant microscopic dimension.